Has the market space advantage

The market of developed countries represented by the United States grows slowly, while the market of developing countries will grow rapidly. Generic drugs are a huge market, and the supply of generic drugs only comes from dozens of large-scale manufacturers, among which there are no Chinese enterprises.

India is a big producer of generic drugs, China has room to chase, and big pharmaceutical companies are beginning to enter the generics field. With the intensification of China's aging population in the future, the domestic demand for related drugs will also show an increasing trend year by year, and domestic pharmaceutical intermediates enterprises will benefit from the rapid progress of the pharmaceutical industry market.

Pharmaceutical production, as an important industry in the field of fine chemical industry, has become the focus of progress and competition in the past 10 years, and the discussion of new drugs in the world in the next few years will focus on the following types of drugs: Brain function improving drugs, anti-rheumatoid arthritis drugs, anti-AIDS drugs, anti-hepatitis and other viral drugs, blood lipids, anti-thrombotic drugs, anti-tumor drugs, platelet activating factor antagonists, glucoside heart enhancers, anti-depression, anti-schizophrenia and anti-anxiety drugs. To develop intermediates for these drugs is an important way to develop the direction of pharmaceutical intermediates and expand new market space in the future.